News

 

 

Funding: New Awards

Marc Ernstoff, MD
Member, Immunology and Cancer Immunotherapy Research Program at Norris Cotton Cancer Center and Professor of Medicine (Hematology-Oncology) at Dartmouth Medical School

  • GlaxoSmithKline Group
    A Phase III Randomized, Open-Label Study Comparing GSK2118436 to DTIC in Previously Untreated Subjects with BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Ryan Halter, PhD
Member, Cancer Imaging & Radiobiology Research Program at Norris Cotton Cancer Center and Assistant Professor of Engineering at Thayer School of Engineering

  • NCI
    Intraoperative Surgical Margin Assessment with Electrical Impedance Spectroscopy (4 year award)

Christopher Lowrey, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center and Professor of Medicine (Hematology-Oncology) and of Pharmacology & Toxicology at Dartmouth Medical School

  • CALGB
    Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High Risk Chronic Lymphocytic Leukemia (CLL)

J Marc Pipas, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center and Associate Professor of Medicine (Hematology-Oncology) at Dartmouth Medical School

  • CALGB
    Randomized Phase II Study of Everolimus Alone Versus Everolimus Plus Bevacizumab in Patients with Locally Advanced of Metastatic Pancreatic Neuroendocrine Tumors